Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$235.51 - $267.98 $1.08 Million - $1.23 Million
-4,600 Reduced 82.14%
1,000 $249,000
Q1 2024

May 13, 2024

BUY
$224.58 - $256.19 $1.26 Million - $1.43 Million
5,600 New
5,600 $1.4 Million
Q2 2023

Aug 09, 2023

BUY
$224.99 - $256.14 $2.11 Million - $2.41 Million
9,400 Added 55.62%
26,300 $6.31 Million
Q1 2023

May 12, 2023

SELL
$239.75 - $277.0 $1.34 Million - $1.55 Million
-5,600 Reduced 24.89%
16,900 $4.26 Million
Q4 2022

Feb 13, 2023

BUY
$241.42 - $282.29 $3.07 Million - $3.59 Million
12,700 Added 129.59%
22,500 $5.97 Million
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $2.12 Million - $13 Million
-8,600 Reduced 46.74%
9,800 $2.53 Million
Q2 2022

Aug 15, 2022

BUY
$237.11 - $299.66 $711,330 - $898,980
3,000 Added 19.48%
18,400 $4.67 Million
Q4 2021

Feb 15, 2022

SELL
$292.08 - $329.01 $2.28 Million - $2.57 Million
-7,800 Reduced 33.62%
15,400 $5.07 Million
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $1.47 Million - $1.8 Million
-5,400 Reduced 18.88%
23,200 $7.06 Million
Q2 2021

Aug 16, 2021

BUY
$225.08 - $271.69 $3.22 Million - $3.89 Million
14,300 Added 100.0%
28,600 $7.68 Million
Q1 2021

May 17, 2021

SELL
$212.38 - $245.9 $254,856 - $295,080
-1,200 Reduced 7.74%
14,300 $3.22 Million
Q4 2020

Feb 12, 2021

SELL
$212.5 - $245.46 $1.17 Million - $1.35 Million
-5,500 Reduced 26.19%
15,500 $3.44 Million
Q3 2020

Nov 12, 2020

BUY
$177.16 - $215.33 $1.05 Million - $1.27 Million
5,900 Added 39.07%
21,000 $4.52 Million
Q2 2020

Aug 06, 2020

SELL
$128.7 - $176.83 $2.79 Million - $3.84 Million
-21,700 Reduced 58.97%
15,100 $2.67 Million
Q1 2020

May 13, 2020

BUY
$121.39 - $169.05 $1.03 Million - $1.44 Million
8,500 Added 30.04%
36,800 $5.09 Million
Q4 2019

Feb 10, 2020

SELL
$133.47 - $153.48 $2.22 Million - $2.55 Million
-16,600 Reduced 36.97%
28,300 $4.34 Million
Q3 2019

Nov 19, 2019

SELL
$135.4 - $146.47 $135,400 - $146,470
-1,000 Reduced 2.18%
44,900 $6.49 Million
Q2 2019

Aug 15, 2019

SELL
$124.88 - $143.73 $1.67 Million - $1.93 Million
-13,400 Reduced 22.6%
45,900 $6.56 Million
Q1 2019

May 14, 2019

SELL
$97.62 - $132.29 $2.39 Million - $3.24 Million
-24,500 Reduced 29.24%
59,300 $7.83 Million
Q3 2018

Oct 16, 2018

SELL
$98.13 - $108.9 $735,975 - $816,750
-7,500 Reduced 8.21%
83,800 $9.11 Million
Q2 2018

Aug 17, 2018

SELL
$96.1 - $103.24 $28,830 - $30,972
-300 Reduced 0.33%
91,300 $9.01 Million
Q1 2018

Apr 10, 2018

SELL
$92.16 - $103.8 $771,655 - $869,117
-8,373 Reduced 8.38%
91,600 $8.97 Million
Q4 2017

Feb 14, 2018

SELL
$85.26 - $94.62 $1.39 Million - $1.54 Million
-16,327 Reduced 14.04%
99,973 $9.28 Million
Q3 2017

Oct 31, 2017

BUY
$79.29 - $88.45 $9.22 Million - $10.3 Million
116,300
116,300 $9.98 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $170B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Andra Ap Fonden Portfolio

Follow Andra Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.